Evidence map›Paper›PMID 30828618›Full record

ArticleLaryngoscope investigative otolaryngology2019

Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses.

Sirli Kerge, Jessi Vuorinen, Saija Hurme, Tero Soukka, Tarik Gheit, Massimo Tommasino, Stina Syrjänen, Jaana Rautava

Abstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sirli KergeDepartment of Oral Diseases Turku University Hospital Turku Finland.
Jessi VuorinenDepartment of Oral Pathology University of Turku Turku Finland.
Saija HurmeDepartment of Biostatistics University of Turku Turku Finland.
Tero SoukkaDepartment of Oral Diseases Turku University Hospital Turku Finland.
Tarik GheitInfections and Cancer Biology Group International Agency for Research on Cancer Lyon France.ORCID https://orcid.org/0000-0001-7088-337X
Massimo TommasinoInfections and Cancer Biology Group International Agency for Research on Cancer Lyon France.
Stina SyrjänenDepartment of Pathology Turku University Hospital Turku Finland.
Jaana RautavaDepartment of Pathology Turku University Hospital Turku Finland.ORCID https://orcid.org/0000-0001-9946-2974

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundOral papillomas and verruca vulgaris have been associated with human papillomavirus (HPV) infection. However, approximately half of these have remained HPV-negative when tested for mucosal HPV genotypes. In this study, we evaluated presence of α-, β-, and γ-HPVs in benign papillary and verrucous lesions.

methodsEighty-three clinical lesions with suspected HPV etiology were analyzed for HPV types of genus α (n = 24), β (n = 46), and γ (n = 52). Immunohistochemistry was used for p16 as a possible surrogate marker of high-risk HPV, accompanied by Ki-67 proliferation marker.

resultsAltogether, α-HPVs were detected in 6.4%, β-HPVs in 2.4%, and γ-HPV in 4.8%. The following genotypes were identified: HPV6, 8, 11, 16, 22, 161, and 170. Neither Ki-67 nor p16 positivity alone were associated with HPV but combined staining showed significant inverse association (

conclusionHPV infection is found only in a minority of benign verrucous and papillary oral lesions, with the predominance of α-HPVs. LEVEL OF EVIDENCE: 4.

Indexed as

benignHPVOralp16papilloma

Identifiers

PMID30828618
PMCPMC6383307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.